Table 1.
Number of patients (n) | 44 |
Number of eyes associated with disease (n) | 74 |
Median age, years (mean ±SD) | 52.64 ± 17.42 |
Eyes with vision loss (n) | 68 |
Eyes with papilledema (n) | 55 |
Ocular pain n (%) | 24 (54.55%) |
Ptosis n (%) | 11 (14.86%) |
Diplopia n (%) | 9 (20/45%) |
Exophthalmos n (%) | 10 (13.51%) |
Visual field defect (n) | 51 |
Central scotoma n (%) | 0 (0%) |
Bjerrum scotoma n (%) | 0 (0%) |
Ring cotoma n (%) | 27 (52.94%) |
Irregular defect n (%) | 16 (31.37%) |
Diffuse visual field defect n (%) | 8 (15.69%) |
Connective tissue disease (n) | 33 |
Graves' disease (n) | 12 |
IgG-4 RD (n) | 10 |
GAP (n) | 4 |
SLE (n) | 2 |
Sarcoidosis (n) | 1 |
Rheumatoid arthritis (n) | 1 |
Scleroderma (n) | 1 |
Behcet's disease (n) | 1 |
Gout (n) | 1 |
Infectious diseases (n) | 10 |
Tuberculosis (n) | 5 |
Sparganosis (n) | 1 |
Ocular toxoplasmosis (n) | 1 |
Bacterial meningitis (n) | 1 |
Fungal meningitis (n) | 1 |
Cytomegalovirus (n) | 1 |
Idiopathic disease (n) | 1 |
GAP, Granulomatosis with Polyangiitis; SLE, systemic lupus erythematosus; IgG-4 RD, immunoglobulin G4-related disease.